Benevolent AI
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
31 aug 2023 - 00:58
Statutory name
Benevolent AI
Title
BenevolentAI doses first participants in clinical trial of BEN-8744; targets PDE10, an AI-derived novel target for the treatment of Ulcerative Colitis
Date last update: 06 April 2026